HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT
0.0.1 - DRAFT
HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT
0.0.1 - DRAFT
HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT, published by HL7 International Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/standardhealth/fsh-ae/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicationAdministration
Resource MedicationAdministration "medication-administration-kadcyla"
status: completed
medication: KADCYLA (RxNorm#1371046)
subject: Patient/patient-example-kaitlyn-b " BOUNCE"
effective: 2020-04-01
| Actor |
| Practitioner/practitioner-oncology-nurse-jane " NURSE" |
reasonReference: Condition/KaitlynPrimaryCancerConditionEx1
request: MedicationRequest/medication-request-example-kadcyla
note: 3.6mg administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/practitioner-oncology-nurse-jane @2020-04-01)
| Route | Dose |
| Intravenous route (qualifier value) (SNOMED CT#47625008) | 3.6 mg (Details: UCUM code mg = 'mg') |